 NEWARK, N.J., Sept. 24, 2021 PRNewswire -- Rafael Holdings, Inc., NYSE: RFL, a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its Barer Institute and investment in Rafael Pharmaceuticals, Inc., announced today the appointment of Ashok Marin, Chief Legal Officer. 